Receptor Kinase Inhibitors Target NSCLC†: Two Antibodies and a Small-Molecule MET Inhibitor

ISSN： 1173-8804

Source： BioDrugs, Vol.25, Iss.4, 2011-08, pp. : 271-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib: A Multitargeted Receptor Tyrosine Kinase Inhibitor in the Era of Molecular Cancer Therapies

By Papaetis Georgios S. Syrigos Kostas N.

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 377-389

Adis International

Access to resources Recommend Favorite

Localized expression of small RNA inhibitors in human cells

By Paul C.P. Good P.D. Li S.X.L. Kleihauer A. Rossi J.J. Engelke D.R.

Molecular Therapy, Vol. 7, Iss. 2, 2003-02 ,pp. : 237-247

Elsevier

Access to resources Recommend Favorite

Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of Glaucoma

By Rao Vasantha P. Epstein David L.

BioDrugs, Vol. 21, Iss. 3, 2007-01 ,pp. : 167-177

Adis International

Access to resources Recommend Favorite

Role of Anti-Interleukin-2 Receptor Antibodies in Kidney Transplantation

By Cibrik D.M. Kaplan B. Meier-Kriesche H-U.

BioDrugs, Vol. 15, Iss. 10, 2001-10 ,pp. : 655-666

Adis International

Access to resources Recommend Favorite

Pneumonitis and esophagitis in NSCLC patients

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 99-99

Nova Science Publishers, Inc.

Access to resources Recommend Favorite